The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Chelseas bus is still in Liverpool, the tyres got nicked!!! GN
Yes, but there's always the next match.
Sean Dyche left early on the team bus leaving the players in the dressing room.
Our football teams today Ray?? lol
Genexine got their Keytruda free by collaborating with Merck.
However, the financial terms of this agreement have not been made public.
https://www.businesswire.com/news/home/20161116005667/en/Genexine-Enters-Clinical-Research-Collaboration-MSD
"Under the terms of the agreement between Genexine and MSD, through a subsidiary of Merck & Co., Inc., Kenilworth, NJ, USA, Genexine will conduct a Phase 1b/2a clinical trial to access safety and efficacy of the combination therapy, and MSD will provide clinical supplies of Keytruda and offer support to the study. The agreement also includes provision for potential expansion to include Phase III registration studies in the same indication. Additional details were not disclosed."
Scancell may have been able to foster a special deal for Keytruda with Nottingham NHS due to their joint relationships with Notts University. Trying to get other cash strapped NHS authorities to stump up for Keytruda may be to big an ask. This is where big pharma with their deep pockets win over small independent biotects every time.
I would think they are trying their level best to open up some more uk sites but considering the current political situation in might be the wrong time. We can but hope.
We need the FDA to pull their finger out....
Chester.
Morning All, and Botski in reply to your post I just avoided adding any more speculation to the SCIB1 Trial, by way of sites, whilst there is so much unknown to us, not at least how we are overcoming any problems that exist.
It is still my hope that we will be able to submit another IND to the FDA, and when/if granted be able to utilise in Keith Flaherty in whatever capacity we can. Are there enough/if any countries able to burden the cost of Keytruda for the trial?? Again it would all be speculation and TBH not sure why it would mean an end to any other UK trial centres. As you know it has been four months or so since we initiated the trial, it will be good just to know of our plans, progress and a Plan B.
Just my observation and views on the last few posts....
For me, the pertinent phrases are “timelines” and “jam tomorrow”.
The dominant issue with this investment and this potentially life saving treatment is TIME or more accurately, the passage of time. In the short term, this gets us to “tomorrow”. Whether or not this brings the long awaited “jam” remains to be seen.
Either way, time will reveal all. In time we will know how effective the treatments are and, if successful, how much in pounds and pennies each of the shares we currently hold are worth.
Time is what is needed and cannot be skipped or accelerated. But as they say, time is money. Each delay will have a financial impact. So our expected £1 or whatever will be £1 minus value of time delay. A simple concept but an inescapable one.
Aimho
Nobody talking about trial centres outside UK and US...is that because people dont expect them to materialize...or because people dont want to draw attention to the fact it may well mean no additional UK trial centres.
I would agree with that Knowlesi in large, I just felt it was good to get simple reminders of what we have in our pipelines, and with news pretty scarce, any cureent news of where we are is welcome.
Moving away from what was said, because there was no new news, I just felt CH has gained so much since he was appointed. Encouraging IMHO that in November 2019, it would seem we are still on target to get MOD1 and SCIB2 into clinical trials. Obviously like everybody waiting to here what we are doing with patient recruitment for the SCIB1 Combo Trial, and just personally looking forward to a good build up for news on MOD1.
Funny enough I didn"t see it as jam tomorrow, there was nothing new stated, but likewise there was nothing negative either, just a good reminder of where we are, where we hope to be and when. I am sure around all that with the TCR, Glycans and Mabs we can look forward to quite a few items of positive newsflow. There are 148 views now on that presentation and I wouldn"t mind betting more than a few of us were reminded or picked up on somethimg we hadn"t previously. ATB
Afternoon All, just two trading weeks to Xmas. Pleased we got that video of Cliff Holloways presentation, at least it felt as if we are ploughing on with purpose, just hoping like all of us for some very good news before the New Year begins to take us into a very critical year.
WTP, no idea about the small red sells, but will be very happy to see this week close with no big sells and maybe another 200k odd bought.
WTP - gotta pay the Gas bill !
...all the tiny sells?